3E0V3GB
Introduction Bones to Recombinant Bone Morphogenetic Protein with Other Therapeutic Substance, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | E Physiological Systems and Anatomical Regions |
| Operation | 0 Introduction |
| Body Part | V Bones |
| Approach | 3 Percutaneous |
| Device | G Other Therapeutic Substance |
| Qualifier | B Recombinant Bone Morphogenetic Protein |
Operation Definition
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Procedure Overview
Introduction covers putting a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance into or onto a body region, other than blood or blood products, which fall under Transfusion instead. This wide-ranging family includes things like injecting anesthesia, infusing chemotherapy, instilling contrast for imaging, delivering anti-infective medications, or providing nutritional formula through a feeding route.
Because it spans so many substance types and delivery sites, this is one of the most frequently used families in the Administration section. A patient might encounter it during an epidural injection, a course of intravenous antibiotics, contrast dye given before a CT scan, or tube feeding after surgery; each represents a substance being placed into the body to achieve a specific therapeutic or diagnostic goal rather than a physical alteration of tissue.
Anatomy & Axis Detail
Bones
Introduction into bone most often refers to intraosseous access, a technique that pushes fluids, medications, or blood products directly into the marrow cavity when peripheral intravenous access is impossible, as in emergency resuscitation of a critically ill patient or a small child in shock. The marrow space is highly vascular and absorbs substances rapidly, making it a reliable backup route even though it is used only temporarily until conventional IV access can be established. Antibiotic-impregnated beads or local antibiotic delivery for osteomyelitis is another example, placing medication directly at the site of bone infection. Coding depends on which specific bone or region received the substance, and clinicians should document the anatomic site and route clearly, since intraosseous access is functionally distinct from injections into surrounding soft tissue.
Approach: Percutaneous
In Administration, Percutaneous denotes a substance delivered by needle injection through the skin, such as an intramuscular or subcutaneous injection, without cutting or scope guidance. It differs from External, where the substance is applied to the skin surface itself, and from Via Natural or Artificial Opening, where it is introduced through an orifice rather than through a puncture.
Substance: Other Therapeutic Substance
Other Therapeutic Substance is a residual category for administered agents intended to treat a condition that do not fit any of the more specific therapeutic device values, such as Antineoplastic, Anti-infective, or Hormone. It is used when the substance's therapeutic intent is clear but its pharmacologic class is not separately classified, distinguishing it from Other Diagnostic Substance, which serves a diagnostic rather than treatment purpose.
Qualifier: Recombinant Bone Morphogenetic Protein
Names a lab-engineered bone morphogenetic protein administered to stimulate bone formation, commonly used in spinal fusion or fracture repair procedures where natural bone healing is insufficient. It is a distinct biologic qualifier separate from Other Hormone because it targets osteogenesis specifically rather than broader endocrine or metabolic functions.
Coding & Documentation
Correct code assignment depends on identifying three things from the documentation: the substance given, matched to the correct qualifier value; the specific body region or route receiving it; and the approach used, such as percutaneous injection or an existing catheter. Physician orders and medication administration records are the primary support. The most common errors involve selecting an imprecise substance qualifier, for example coding a general anti-infective when the documentation specifies a particular drug category with its own value, or misidentifying the body region when a substance is delivered systemically versus locally, such as an intra-articular injection versus an intravenous one.
Commonly Confused With
This family is easily confused with Transfusion, but any blood or blood product is excluded here and must be coded under Transfusion instead, regardless of how it is delivered. It is also confused with routine medication administration that some facilities do not code separately when it is considered standard nursing care rather than a notable procedural event; coders should apply their facility's guidelines to determine which introductions rise to the level of a codable procedure.